Increased frequency of NKG2C+ NK cells was linked to greater disease severity, with approximately 2/3 of CMV+ severe COVID-19 patients demonstrating adaptive NK cell expansion compared to 1/3 of CMV+ healthy controls and even fewer CMV+ moderate COVID-19 patients [83]. The gene discussed is KLRC2; the disease is COVID-19.